Aclaris Therapeutics, Inc.
ACRS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001557746
No open-market purchases or sales by Aclaris Therapeutics, Inc. insiders were filed in the last 90 days; 148 institutions reported holding it in 13F filings for Q2 2026, worth $630.0M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Aclaris Therapeutics, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 110
- −20 vs. Q4 2021
- Shares held
- 59.3M
- +3.52M (+6.3%) vs. Q4 2021
- Total value
- $1.02B
- +$210.9M (+26.0%) vs. Q4 2021
- New holders
- 10
- 37 more added
- Sold out
- 30
- 43 more reduced
3 institutions that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ACRS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 148 | $630.0M |
| Q1 2026 | 136 | $409.4M |
| Q4 2025 | 122 | $252.1M |
| Q3 2025 | 103 | $162.8M |
| Q2 2025 | 96 | $130.4M |
| Q1 2025 | 109 | $143.8M |
| Q4 2024 | 98 | $217.0M |
| Q3 2024 | 81 | $58.5M |
| Q2 2024 | 98 | $58.1M |
| Q1 2024 | 98 | $67.5M |
| Q4 2023 | 107 | $61.4M |
| Q3 2023 | 138 | $480.0M |
| Q2 2023 | 133 | $737.2M |
| Q1 2023 | 149 | $579.3M |
| Q4 2022 | 128 | $1.04B |
| Q3 2022 | 127 | $1.00B |
| Q2 2022 | 115 | $883.3M |
| Q1 2022 | 110 | $1.02B |
| Q4 2021 | 133 | $814.9M |
| Q3 2021 | 126 | $1.02B |
| Q2 2021 | 128 | $983.4M |
| Q1 2021 | 97 | $1.14B |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Aclaris Therapeutics, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Signaturefd, LLC | 43 | $1.00K | 0.00% | −20−31.7% | Reduced |
| Massmutual Trust Co FSB | 55 | $1.00K | 0.00% | +55 | New |
| Quadrant Capital Group LLC | 84 | $1.00K | 0.00% | +84 | New |
| Daiwa Securities Group Inc. | 179 | $3.00K | 0.00% | 00.0% | Unchanged |
| Lindbrook Capital, LLC | 208 | $4.00K | 0.00% | +208 | New |
| Northwestern Mutual Wealth Management Co | 500 | $9.00K | 0.00% | 00.0% | Unchanged |
| High Net Worth Advisory Group LLC | 500 | $9.00K | 0.00% | +500 | New |
| Parallel Advisors, LLC | 600 | $11.0K | 0.00% | +600 | New |
| Tower Research Capital LLC (TRC) | 1,300 | $22.0K | 0.00% | −151−10.4% | Reduced |
| Macquarie Group Ltd | 1,568 | $27.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1,702 | $29.0K | 0.00% | −44,486−96.3% | Reduced |
| Great West Life Assurance Co | 1,944 | $36.0K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 2,712 | $47.0K | 0.00% | −707−20.7% | Reduced |
| Metropolitan Life Insurance Co | 2,996 | $51.7K | 0.00% | −9,700−76.4% | Reduced |
| Royal Bank of Canada | 3,137 | $54.0K | 0.00% | −7,590−70.8% | Reduced |
| Cubist Systematic Strategies, LLC | 3,429 | $59.0K | 0.00% | −17,583−83.7% | Reduced |
| Ameritas Investment Partners, Inc. | 3,979 | $69.0K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 4,426 | $76.3K | 0.00% | −6,426−59.2% | Reduced |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 7,501 | $129.0K | 0.00% | 00.0% | Unchanged |
| Allspring Global Investments Holdings, LLC | 7,726 | $133.0K | 0.00% | −833−9.7% | Reduced |
| Amalgamated Bank | 8,306 | $143.0K | 0.00% | +8,306 | New |
| Amalgamated Financial Corp. | 8,306 | $143.0K | 0.00% | +8,306 | New |
| Citigroup Inc | 8,392 | $145.0K | 0.00% | −9,199−52.3% | Reduced |
| AQR Capital Management LLC | 10,816 | $186.0K | 0.00% | −9,119−45.7% | Reduced |
| Hyperion Capital Advisors LP | 10,861 | $187.0K | 0.07% | 00.0% | Unchanged |
| Ensign Peak Advisors, Inc | 10,970 | $189.0K | 0.00% | 00.0% | Unchanged |
| Occudo Quantitative Strategies LP | 11,766 | $203.0K | 0.02% | −9,377−44.4% | Reduced |
| Ikarian Capital, LLC | 12,124 | $208.0K | 0.06% | +1,339+12.4% | Added |
| Arizona State Retirement System | 12,413 | $214.0K | 0.00% | +56+0.5% | Added |
| Simplex Trading, LLC | 12,482 | $215.0K | 0.01% | −11,717−48.4% | Reduced |
| Blackstone Group Inc. | 13,033 | $225.0K | 0.00% | 00.0% | Unchanged |
| Handelsbanken Fonder AB | 13,800 | $238.0K | 0.00% | 00.0% | Unchanged |
| Cambridge Investment Research Advisors, Inc. | 15,338 | $264.0K | 0.00% | 00.0% | Unchanged |
| ProShare Advisors LLC | 15,905 | $274.0K | 0.00% | −3,855−19.5% | Reduced |
| X-Square Capital, LLC | 16,000 | $276.0K | 0.14% | 00.0% | Unchanged |
| Legal & General Group Plc | 16,601 | $286.0K | 0.00% | +876+5.6% | Added |
| Telemetry Investments, L.L.C. | 19,011 | $328.0K | 0.52% | −10,989−36.6% | Reduced |
| Voya Investment Management LLC | 20,008 | $345.0K | 0.00% | 00.0% | Unchanged |
| Manufacturers Life Insurance Company, The | 21,195 | $365.4K | 0.00% | −5,300−20.0% | Reduced |
| DekaBank Deutsche Girozentrale | 22,000 | $388.0K | 0.00% | +2,000+10.0% | Added |
| Invesco Ltd. | 24,076 | $415.0K | 0.00% | −263−1.1% | Reduced |
| American International Group, Inc. | 25,323 | $437.0K | 0.00% | −1,783−6.6% | Reduced |
| MetLife Investment Management | 26,282 | $453.1K | 0.00% | +9,700+58.5% | Added |
| Susquehanna International Group, LLP | 29,100 | $502.0K | 0.00% | +5,409+22.8% | Added |
| Morgan Stanley | 30,939 | $532.0K | 0.00% | −11,930−27.8% | Reduced |
| Bank of America Corp | 31,314 | $540.0K | 0.00% | −29,344−48.4% | Reduced |
| Price T Rowe Associates Inc | 31,569 | $544.0K | 0.00% | −774−2.4% | Reduced |
| Credit Suisse AG | 31,952 | $550.0K | 0.00% | +3,222+11.2% | Added |
| Principal Financial Group Inc | 32,253 | $556.0K | 0.00% | −13,152−29.0% | Reduced |
| New York State Common Retirement Fund | 38,955 | $672.0K | 0.00% | +7,628+24.3% | Added |
| Wells Fargo & Company | 39,811 | $686.0K | 0.00% | +7,013+21.4% | Added |
| Alliancebernstein L.P. | 41,800 | $721.0K | 0.00% | +9,200+28.2% | Added |
| JPMorgan Chase & Co | 44,650 | $770.0K | 0.00% | +7,448+20.0% | Added |
| Parametric Portfolio Associates LLC | 45,497 | $784.0K | 0.00% | +20,364+81.0% | Added |
| UBS Asset Management Americas Inc | 49,346 | $850.7K | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 55,194 | $952.0K | 0.00% | +8,469+18.1% | Added |
| Millennium Management LLC | 56,213 | $969.0K | 0.00% | −296,294−84.1% | Reduced |
| State of Wisconsin Investment Board | 56,300 | $971.0K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 60,256 | $1.04M | 0.00% | −40,262−40.1% | Reduced |
| California State Teachers Retirement System | 60,986 | $1.05M | 0.00% | −5,474−8.2% | Reduced |
| HighTower Advisors, LLC | 63,299 | $1.09M | 0.00% | −4,580−6.7% | Reduced |
| Teachers Retirement System of the State of Kentucky | 66,814 | $1.15M | 0.01% | +4,508+7.2% | Added |
| Ameriprise Financial Inc | 76,052 | $1.31M | 0.00% | +1,794+2.4% | Added |
| Allianz Asset Management GmbH | 81,965 | $1.41M | 0.00% | +25,125+44.2% | Added |
| Affinity Asset Advisors, LLC | 100,000 | $1.72M | 0.68% | −300,000−75.0% | Reduced |
| Swiss National Bank | 108,500 | $1.87M | 0.00% | +7,500+7.4% | Added |
| Ghost Tree Capital, LLC | 125,000 | $2.15M | 1.07% | −200,000−61.5% | Reduced |
| Charles Schwab Investment Management Inc | 133,068 | $2.29M | 0.00% | +4,155+3.2% | Added |
| HighVista Strategies LLC | 158,243 | $2.73M | 1.73% | +46,083+41.1% | Added |
| Bank of New York Mellon Corp | 185,596 | $3.20M | 0.00% | −726−0.4% | Reduced |
| Balyasny Asset Management LLC | 209,636 | $3.61M | 0.02% | −256,764−55.1% | Reduced |
| Acuta Capital Partners, LLC | 217,600 | $3.75M | 1.78% | +119,600+122.0% | Added |
| Integral Health Asset Management, LLC | 238,000 | $4.10M | 1.07% | +38,000+19.0% | Added |
| Verition Fund Management LLC | 255,478 | $4.40M | 0.08% | +77,168+43.3% | Added |
| Goldman Sachs Group Inc | 258,459 | $4.46M | 0.00% | +37,267+16.8% | Added |
| Silverarc Capital Management, LLC | 275,333 | $4.75M | 2.58% | −10,893−3.8% | Reduced |
| Nuveen Asset Management, LLC | 317,540 | $5.12M | 0.00% | +15,384+5.1% | Added |
| Perceptive Advisors LLC | 383,239 | $6.61M | 0.14% | −397,997−50.9% | Reduced |
| Frazier Life Sciences Management, L.P. | 408,329 | $7.04M | 0.60% | +408,329 | New |
| Adage Capital Partners GP, L.L.C. | 425,000 | $7.33M | 0.01% | −474,997−52.8% | Reduced |
| Northern Trust Corp | 470,166 | $8.11M | 0.00% | −19,630−4.0% | Reduced |
| Schonfeld Strategic Advisors LLC | 472,760 | $8.15M | 0.09% | −17,700−3.6% | Reduced |
| Assenagon Asset Management S.A. | 507,435 | $8.75M | 0.03% | +507,435 | New |
| Aisling Capital Management LP | 634,455 | $10.9M | 5.90% | 00.0% | Unchanged |
| Parkman Healthcare Partners LLC | 668,098 | $11.5M | 3.37% | −357,424−34.9% | Reduced |
| Samsara BioCapital, LLC | 794,171 | $13.7M | 3.46% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 846,391 | $14.6M | 0.00% | +37,929+4.7% | Added |
| Vivo Capital, LLC | 898,631 | $15.5M | 1.07% | −22,351−2.4% | Reduced |
| Great Point Partners LLC | 942,445 | $16.2M | 3.93% | +142,445+17.8% | Added |
| Citadel Advisors LLC | 972,200 | $16.8M | 0.02% | −39,572−3.9% | Reduced |
| State Street Corp | 1,083,390 | $18.7M | 0.00% | +36,000+3.4% | Added |
| TCG Crossover Management, LLC | 1,144,939 | $19.7M | 7.92% | +62,726+5.8% | Added |
| FMR LLC | 1,213,350 | $20.9M | 0.00% | −266,639−18.0% | Reduced |
| Foresite Capital Management V, LLC | 1,258,243 | $21.7M | 8.86% | 00.0% | Unchanged |
| Laurion Capital Management LP | 1,440,075 | $24.8M | 0.59% | +325,000+29.1% | Added |
| Renaissance Technologies LLC | 1,457,578 | $25.1M | 0.03% | −219,300−13.1% | Reduced |
| Deutsche Bank AG | 1,467,103 | $25.3M | 0.01% | +1,213,032+477.4% | Added |
| OrbiMed Advisors LLC | 1,579,900 | $27.2M | 0.44% | +594,000+60.2% | Added |
| Ra Capital Management, L.P. | 1,817,808 | $31.3M | 0.68% | +1,817,808 | New |
| Holocene Advisors, LP | 2,060,918 | $35.5M | 0.19% | +2,300+0.1% | Added |